<DOC>
	<DOCNO>NCT01365702</DOCNO>
	<brief_summary>The aim study evaluate clinical efficacy tiotropium patient airflow obstruction due Tuberculosis ( TB ) destroy lung .</brief_summary>
	<brief_title>Tiotropium Patients With Tuberculosis ( TB ) Destroyed Lung</brief_title>
	<detailed_description>Tuberculosis cause lung parenchymal destruction , volume loss , secondary bronchiectasis . Patients TB destroy lung complain chronic respiratory symptom , chronic cough , sputum , dyspnea , exercise intolerance , acute exacerbation . Some chronic airflow obstruction pulmonary function test , similar smoker . Previous large randomize controlled trial , target patient smoke related moderate severe COPD , demonstrate tiotropium improve quality life respiratory symptom tolerable long-term safety . The investigator want evaluate whether tiotropium improve chronic respiratory symptom , lung function patient COPD due TB destroy lung .</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>previous pulmonary tuberculosis history never smoker light smoker ( &lt; 10 packyear ) destruction lung parenchyme , lung volume loss , secondary bronchiectasis due tuberculosis chest radiograph chest CT , confirm boardcertificate radiologist airflow obstruction confirm pulmonary function test , FEV1/FVC &lt; 70 % patient agree study enrollment patient active tuberculosis current antituberculous medication patient chemotherapy immunosuppressant therapy glucocorticoid . active infection pneumonia , tuberculosis patient illiterate patient dementia pregnant pregnant previous lung resection surgery history</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>COPD</keyword>
	<keyword>tiotropium</keyword>
	<keyword>tuberculous destroy lung</keyword>
</DOC>